연구동향 분석

High Seroprevalence and Index of Anti-John-Cunningham Virus Antibodies in Korean Patients with Multiple Sclerosis

김수현 김예슬 정지윤 박나영 장현민 현재원 김호진 2019년

논문상세정보
인용/피인용
' High Seroprevalence and Index of Anti-John-Cunningham Virus Antibodies in Korean Patients with Multiple Sclerosis' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Asia.
  • antibodies
  • index
  • johncunninghamvirus
  • progressive multifocal leukoencephalopathy
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
64 0

0.0%

' High Seroprevalence and Index of Anti-John-Cunningham Virus Antibodies in Korean Patients with Multiple Sclerosis' 의 참고문헌

  • Transmission of the human polyomavirus JC virus occurs both within the family and outside the family
    Kitamura T [1994]
  • Therapy with natalizumab is associated with high JCV seroconversion and rising JCV index values
    Schwab N [2016]
  • Systematic review of the published data on the worldwide prevalence of John Cunningham virus in patients with multiple sclerosis and neuromyelitis optica
  • Study of the anti-JCV antibody levels in a Spanish multiple sclerosis cohort
  • Stability and predictive value of anti-JCV antibody index in multiple sclerosis : a 6-year longitudinal study
    Hegen H [2017]
  • Serum anti-John Cunningham virus antibody seroprevalence and index among Japanese patients with neuromyelitis optica spectrum disorders
  • Serum anti-JCV antibody indexes in Japanese patients with multiple sclerosis : elevations along with fingolimod treatment duration
    Aoyama S [2018]
  • Risk of natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis : a retrospective analysis of data from four clinical studies
    Ho PR [2017]
  • Risk of natalizumab-associated progressive multifocal leukoencephalopathy
    Bloomgren G [2012]
  • Rising JCV-Ab index during natalizumab therapy for MS : Inauspicious for a highly efficacious drug
    Javed A [2016]
  • Progressive multifocal leukoencephalopathy(PML)development is associated with mutations in JC virus capsid protein VP1 that change its receptor specificity
    Gorelik L [2011]
  • Parentto-child transmission is relatively common in the spread of the human polyomavirus JC virus
    Kunitake T [1995]
  • PML risk stratification using anti-JCV antibody index and L-selectin
    Schwab N [2016]
  • Natalizumab-associated PML : challenges with incidence, resulting risk, and risk stratification
    Schwab N [2017]
  • Multiplex qPCR assay for ultra sensitive detection of JCV DNA with simultaneous identification of genotypes that discriminates non-virulent from virulent variants
  • Mechanisms of immune escape in central nervous system infection with neurotropic JC virus variant
    Jelcic I [2016]
  • Longitudinal JCV serology in multiple sclerosis patients preceding natalizumab-associated progressive multifocal leukoencephalopathy
    Vennegoor A [2015]
  • Lipid-specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumab
    Villar LM [2015]
  • JC polyomavirus mutants escape antibody-mediated neutralization
    Ray U [2015]
  • JC polyomavirus infection is strongly controlled by human leucocyte antigen class II variants
    Sundqvist E [2014]
  • Infectious entry and neutralization of pathogenic JC polyomaviruses
  • High prevalence and indexes of anti-John Cunningham virus antibodies in a cohort of Chinese patients with multiple sclerosis
    Lau A [2018]
  • High cumulative JC virus seroconversion rate during long-term use of natalizumab
    Vennegoor A [2016]
  • Genotype profile of human polyomavirus JC excreted in urine of immunocompetent individuals
    Agostini HT [1996]
  • Drug-associated progressive multifocal leukoencephalopathy in multiple sclerosis patients
  • Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
    Polman CH [2005]
  • Diagnostic criteria for multiple sclerosis : 2010 revisions to the McDonald criteria
    Polman CH [2011]
  • BK polyomavirus genotypes Ia and Ib1 exhibit different biological properties in renal transplant recipients
    Varella RB [2018]
  • Anti-JCV antibody serostatus and longitudinal evaluation in a Portuguese multiple sclerosis population
    Correia I [2017]
  • Anti-JC virus seroprevalence in a Finnish MS cohort
    Kolasa M [2016]
  • Anti-JC virus antibody titres increase over time with natalizumab treatment
    Raffel J [2015]
  • Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy
    Plavina T [2014]
  • Anti-JC virus antibodies in rituximab-treated patients with neuromyelitis optica spectrum disorder
    Kim SH [2015]
  • A second-generation ELISA(STRATIFY JCVTM DxSelectTM)for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification
    Lee P [2013]